Protagonist Therapeutics Inc
PTGXLatest QuantConomy context for PTGX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Protagonist Therapeutics Inc
QuantConomy has a structured record for PTGX. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- PTGX
- Name
- Protagonist Therapeutics Inc
- Coverage
- 3 market/data records
- Sources
- fmp alpaca alphavantage sec nasdaq
Recent signals for PTGX
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| earnings release | neutral | 40 | Feb 25, 12:00 AM | PTGX filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-25. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| executive change | neutral | 85 | Jun 18, 08:35 PM | PTGX filed 8-K: Director or Officer Changes, Shareholder Vote Results - 1 material event - [very strong neutral signal] |
| large sale | slightly bullish | 32 | May 15, 12:08 AM | PATEL DINESH V PH D exercised options for PTGX shares ($1.62M) - 75000 shares - [very weak slightly bullish signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| PTGX | NASDAQ | fmp | Protagonist Therapeutics, Inc. |
| PTGX | NASDAQ | alpaca | Protagonist Therapeutics, Inc. Common Stock |
| PTGX | NASDAQ | alphavantage | Protagonist Therapeutics Inc |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Waddill William D. | Insider | exercise | 9,000 | $16.54 | $148,860 | 4 on EDGAR |
| Jun 10, 2026 | Waddill William D. | Insider | exercise | 3,000 | $11.80 | $35,400 | 4 on EDGAR |
| May 29, 2026 | Waddill William D. | Insider | exercise | 9,000 | $11.80 | $106,200 | 4 on EDGAR |
| May 12, 2026 | PATEL DINESH V PH D | President and CEO | exercise | 75,000 | $21.58 | $1,618,500 | 4 on EDGAR |
| May 12, 2026 | PATEL DINESH V PH D | President and CEO | exercise | 75,000 | $21.58 | $1,618,500 | 4 on EDGAR |
| May 7, 2026 | Giraudo Bryan | Insider | exercise | 24,000 | $6.45 | $154,800 | 4 on EDGAR |
| Apr 23, 2026 | PATEL DINESH V PH D | President and CEO | gift | 1,460 | $0.00 | $0 | 4 on EDGAR |
| Apr 20, 2026 | Ali Asif | Chief Financial Officer | sale | 1,750 | $105.47 | $184,573 | 4 on EDGAR |
| Mar 26, 2026 | Ali Asif | Chief Financial Officer | exercise | 19,500 | $19.19 | $374,205 | 4 on EDGAR |
| Mar 26, 2026 | SELICK HAROLD E | Insider | exercise | 24,000 | $12.88 | $309,120 | 4 on EDGAR |
| Mar 26, 2026 | MOLINA ARTURO MD | Chief Medical Officer | exercise | 15,000 | $8.04 | $120,600 | 4 on EDGAR |
| Mar 23, 2026 | PATEL DINESH V PH D | President and CEO | gift | 50,000 | $0.00 | $0 | 4 on EDGAR |
| Feb 6, 2026 | Waddill William D. | Insider | exercise | 20,000 | $8.31 | $166,200 | 4 on EDGAR |
| Jan 27, 2026 | Ali Asif | Chief Financial Officer | exercise | 16,000 | $19.19 | $307,040 | 4 on EDGAR |
| Jan 23, 2026 | PATEL DINESH V PH D | President and CEO | gift | 6,000 | $0.00 | $0 | 4 on EDGAR |
| Jan 23, 2026 | MOLINA ARTURO MD | Chief Medical Officer | sale | 13,151 | $82.42 | $1,083,905 | 4 on EDGAR |
| Jan 20, 2026 | Ali Asif | Chief Financial Officer | sale | 8,588 | $82.48 | $708,338 | 4 on EDGAR |
| Jan 20, 2026 | MOLINA ARTURO MD | Chief Medical Officer | sale | 9,514 | $82.48 | $784,715 | 4 on EDGAR |
| Jan 20, 2026 | PATEL DINESH V PH D | President and CEO | sale | 34,438 | $82.48 | $2,840,446 | 4 on EDGAR |
| Jan 9, 2026 | SELICK HAROLD E | Insider | exercise | 14,299 | $4.21 | $60,199 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query PTGX context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access